Alexandre Detappe | Nanomedicine Award | Young Scientist Award

Posted on 09/03/202409/03/2024 by ScienceFather

Prof. Alexandre Detappe | Nanomedicine Award | Young Scientist Award

Prof. Alexandre Detappe, ICANS, France

Prof. Alexandre Detappe is a distinguished biophysicist and a leading figure in cancer research. Holding a PhD from the University of Lyon, France, he has contributed significantly to understanding and combating diseases like multiple myeloma and HER2+ breast cancer. Currently a Professor at Strasbourg Medical School, his research focuses on developing innovative drug delivery systems and small molecules to enhance immune responses against cancer. With extensive academic and institutional appointments, he co-founded several biotech companies, reflecting his commitment to translating research into practical solutions. Detappe’s multifaceted expertise and leadership in translational medicine make him a pivotal figure in advancing cancer therapeutics. 🧬🩺🔬

PUBLICATION PROFILE

Orcid

EDUCATION

Dr. Alexandre Detappe is a distinguished scholar in biophysics, with a rich educational background spanning renowned institutions in France. He earned his Bachelor’s degree in Physics and Science for Engineering from the University of Strasbourg in 2010. Subsequently, he pursued a Master’s degree in Medical Physics at the University of Grenoble, graduating in 2012. Dr. Detappe furthered his expertise with a Medical Physics residency at CEA Saclay in 2012-2013. His academic journey culminated in a PhD in Biophysics from the University of Lyon in 2017, followed by obtaining French authorization to supervise research from the University of Strasbourg in 2020. 🎓🔬

AWARDS

Dr. Alexandre Detappe’s groundbreaking contributions in biophysics and cancer research have garnered him numerous prestigious awards and fellowships. In 2021, he was honored with the Guy Ourisson Award by Cercle Gutenberg/University of Strasbourg, recognizing his outstanding achievements. His exceptional work also earned him the Brigitte Mérand Award from the Force Hémato Foundation in 2020 and the Brian D Novis Research Grant Award from the International Myeloma Foundation. Notably, his research excellence was acknowledged with the ASH Abstract Achievement Award in 2018 and the Marie Curie Award for the Best PhD in Radiation Oncology in 2016. Dr. Detappe’s accolades highlight his significant contributions to advancing medical science. 🏆🔬

RESEARCH FOCUS

Dr. Alexandre Detappe’s research spans various facets of cancer therapy and imaging, with a particular focus on leveraging nanotechnology for improved treatment outcomes. He explores innovative strategies such as nanoparticle-mediated drug delivery, image-guided radiation therapy, and molecular targeting. His work aims to enhance treatment efficacy while minimizing side effects, particularly in cancers like multiple myeloma and breast cancer. Through a multidisciplinary approach integrating biophysics, molecular biology, and nanomedicine, Dr. Detappe pioneers advancements in precision medicine, striving to make cancer therapies more effective and accessible. 🧬⚗️🔬

PUBLICATION TOP NOTES

Subcutaneous Administration of a Zwitterionic Chitosan-Based Hydrogel for Controlled Spatiotemporal Release of Monoclonal Antibodies.

Influence of pneumatic transportation on the stability of monoclonal antibodies.

Site-Selective Protein Conjugation by a Multicomponent Ugi Reaction.

An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering

Molecular bottlebrush prodrugs as mono- and triplex combination therapies for multiple myeloma.

Clinically Translatable Transcrocetin Delivery Platform for Correction of Tumor Hypoxia and Enhancement of Radiation Therapy Effects.

A Combination of Native LC-MS Approaches for the Comprehensive Characterization of the Antibody-Drug Conjugate Trastuzumab Deruxtecan.

Optimal Physicochemical Properties of Antibody–Nanoparticle Conjugates for Improved Tumor Targeting

Anti‐BCMA Immuno‐NanoPET Radiotracers for Improved Detection of Multiple Myeloma

Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation

Amitis Ramezani | Infectious Diseases | Best Researcher Award

Posted on 03/02/202403/02/2024 by ScienceFather

Prof. Amitis Ramezani | Infectious Diseases | Best Researcher Award

Prof. Amitis Ramezani, Pasteur Institute of Iran, Iran

Prof. Amitis Ramezani is an accomplished Infectious Disease Specialist and MPH holder from Tehran University of Medical Sciences. As Head of Clinical Research, Epidemiology, and Biostatistics Group, she contributes significantly to infectious disease research. Serving as Editor-in-Chief of the Iranian Journal of Infectious Diseases and Tropical Medicine, and holding various editorial positions, Prof. Ramezani is deeply involved in academic publishing. Her extensive memberships in global infectious disease societies and contributions to numerous research projects, especially in COVID-19 and HIV/AIDS, showcase her commitment to public health. 🌐

Publication Profile:

Scopus

Orcid

Education and Qualifications:

Prof. Amitis Ramezani is a distinguished Infectious Disease Specialist, having earned her credentials from Tehran University of Medical Sciences. With expertise in public health, she furthered her education with a Master’s in Public Health from the Faculty of Health, Tehran University of Medical Sciences. 🩺💡 As a leader in infectious disease research, Prof. Ramezani holds key positions, including Head of Clinical Research, Epidemiology, and Biostatistics Group. Her commitment extends to editorial roles in reputable journals, shaping academic discourse. Passionate about global health, she actively engages in research projects, particularly in the critical areas of COVID-19 and HIV/AIDS. 🌍🔬

Employment:

Prof. Amitis Ramezani serves as an academic member and researcher in the Clinical Research Department at the Pasteur Institute of Iran in Tehran. 🏛️🔬 Her role underscores her dedication to advancing clinical research within this prestigious institution. As an esteemed academic, she contributes significantly to the institute’s scholarly endeavors, further enriching its research landscape. This position aligns with her expertise in infectious diseases and public health, reflecting a commitment to advancing medical knowledge and fostering scientific excellence. Prof. Ramezani’s affiliation with the Pasteur Institute exemplifies her ongoing contribution to cutting-edge research and academic pursuits in the field of healthcare.

Awards:

Prof. Amitis Ramezani stands adorned with accolades, including Certificates of Best Society for her tireless efforts during the challenging COVID-19 pandemic in 2021. 🏆 Amidst her achievements, she garnered Certificates of Appreciation from the Iranian Medical Council in 2019 for being among the best-selected individuals in the medical community. 🌐👩‍⚕️ Furthermore, her commitment to excellence earned her the prestigious title of Best Assistant Professor at the Pasteur Institute of Iran in 2010. Notably, her scholarly contributions were recognized early in her career when she clinched the Tehran University Book Award in 2001, showcasing her enduring dedication to advancing medical knowledge.

Research Focus:

Dr. Amitis Ramezani, an accomplished researcher and infectious disease specialist, has made significant contributions to the medical field. 🩺 Her research focuses on diverse aspects, ranging from the long-term manifestations of COVID-19 and vaccination to immunogenicity and safety of COVID-19 boosters. 🦠⚕️ With a keen interest in infectious diseases, her studies encompass areas such as SARS-CoV-2 viral shedding, HIV vaccines, and the epidemiology of various viral infections in Iran. 🌍🔬 Dr. Ramezani’s extensive work underscores her commitment to advancing our understanding of infectious diseases, contributing valuable insights to global health.

Publication Top Notes:

Long-term rheumatoid manifestations as a consequence of COVID-19 and/or vaccination: A case report after a 2-year follow-up

A Comparative Study of Immunogenicity, Antibody Persistence, and Safety of Three Different COVID-19 Boosters between Individuals with Comorbidities and the Normal Population

Safety, Immunogenicity, and Antibody Persistence of COVID-19 Boosters in BBIP-CorV Immunized Individuals with Comorbidities

A Landscape on Disorders Following Different COVID-19 Vaccination: A Systematic Review of Iranian Case Reports

Evaluating the Factors Affecting COVID-19 Patients’ Mortality in Arak in 2020

Characterization of long COVID-19 manifestations and its associated factors: A prospective cohort study from Iran

Manifestations, complications, and treatment of neurobrucellosis: a systematic review and meta-analysis

SARS-CoV-2 Viral Shedding and Associated Factors among COVID-19 Inpatients and Outpatients

Determination of Human Papillomavirus Type 18 Lineage of E6: A Population Study from Iran

HIV-1 p24-nef DNA Vaccine Plus Protein Boost Expands T-Cell Responses in BALB/c

Muhammad Sohaib Asghar | Internal Medicine | Young Scientist Award

Posted on 09/01/202419/01/2024 by ScienceFather

Dr.Muhammad Sohaib Asghar | Internal Medicine |Young Scientist Award

MD at AdventHealth Sebring, United States

Dr. Muhammad Sohaib Asghar is a dedicated healthcare professional with a diverse background in internal medicine and nephrology research. Currently serving as a Resident Physician at AdventHealth Florida, he previously held key roles at Mayo Clinic in the USA and Dow University Hospital in Pakistan. Dr. Asghar is board-certified by the Pakistan Medical Council and the College of Physicians and Surgeons Pakistan. His academic excellence is underscored by numerous distinctions and honors during medical school, complemented by a passion for sports, earning championships in badminton and football. A well-rounded achiever, Dr. Asghar is committed to advancing healthcare with a focus on nephrology.

Publication Profile :

Scopus

Orcid

Education, Previous Professional Position And Major Appointments :

Dr. Muhammad Sohaib Asghar is a seasoned medical professional, currently serving as a Resident Physician in the Department of Internal Medicine at AdventHealth Florida. With a strong foundation in nephrology research, he held key roles at the prestigious Mayo Clinic in Rochester, MN, USA. His earlier experiences include serving as a Medical Resident and Medical Officer in nephrology and transplant medicine at Dow University Hospital, Karachi, Pakistan. Dr. Asghar’s medical journey began with internships at Liaquat National Hospital and Abbasi Shaheed Hospital. A graduate of Liaquat National Hospital and Medical College, he brings a wealth of expertise and commitment to advancing healthcare. 🏥💉

Honors | Awards :

Dr. Muhammad Sohaib Asghar is a distinguished medical professional with a stellar academic record, earning cash prizes for academic excellence during his medical school years. Beyond his achievements in the academic realm, he showcased exceptional sporting prowess, securing championships in badminton and football throughout his medical school journey. Recognized for his outstanding research contributions, Dr. Asghar received prestigious awards at national and international conferences, including a notable cash prize and travel grants. His commitment to patient safety was honored with the Dr. Tahir Shamsi Patient Safety Research Award. Now a Fellow of the American Society for Microbiology, he continues to excel, earning a Travel Fellowship for the ASM Annual Meeting in Houston. 🏆🔬

Research Focus :

Dr. Muhammad Sohaib Asghar, a versatile researcher, has a diverse research focus spanning cardiology, nephrology, infectious diseases, and public health. His extensive contributions include studies on substance-induced cardiomyopathy, nephrotic syndrome treatments, diabetes, and COVID-19-related issues. 🫀🧬 His commitment to global health is evident in investigations into infectious outbreaks like monkeypox and Ebola. With a keen interest in patient outcomes, Dr. Asghar delves into topics like kidney biopsy prognostics and the impact of COVID-19 on acute kidney injury. 🌐 His work reflects a holistic approach to medical research, addressing multifaceted challenges for the betterment of healthcare. 🏥🔍

Publication Top Notes :

1.Trends in substance-induced cardiomyopathy-related mortality among older adults in the United States from 1999 to 2020

2.Meta-analysis on the efficacy and safety of rituximab versus tacrolimus for nephrotic syndrome in the paediatric age group

3.Efficacy of anti‐CD3 monoclonal antibodies in delaying the progression of recent‐onset type 1 diabetes mellitus: A systematic review, meta‐analyses and meta‐regression

4.Hyponatremia causing factors and its association with disease severity and length of stay in COVID-19 patients: A retrospective study from tertiary care hospital

5.Role of soluble urokinase type plasminogen activator receptor (suPAR) in predicting mortality, readmission, length of stay and discharge in emergency patients: A systematic review and meta analysis